Cargando…
A Phase 3, Randomized, Placebo‐Controlled Evaluation of the Safety of Intravenous Meloxicam Following Major Surgery
An intravenous (IV) formulation of meloxicam is being studied for moderate to severe pain management. This phase 3, randomized, multicenter, double‐blind, placebo‐controlled trial evaluated the safety of once‐daily meloxicam IV 30 mg in subjects following major elective surgery. Eligible subjects we...
Autores principales: | Bergese, Sergio D., Melson, Timothy I., Candiotti, Keith A., Ayad, Sabry S., Mack, Randall J., McCallum, Stewart W., Du, Wei, Gomez, Alexis, Marcet, Jorge E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899482/ https://www.ncbi.nlm.nih.gov/pubmed/30786162 http://dx.doi.org/10.1002/cpdd.666 |
Ejemplares similares
-
Platelet Function: Meloxicam Intravenous in Whole Blood Samples From Healthy Volunteers
por: Jahr, Jonathan S., et al.
Publicado: (2020) -
Safety and efficacy of an intravenous nanocrystal formulation of meloxicam in the management of moderate to severe pain following laparoscopic abdominal surgery
por: Singla, Neil, et al.
Publicado: (2018) -
Efficacy and Safety of Intravenous Meloxicam in Subjects with Moderate-to-severe Pain Following Abdominoplasty
por: Singla, Neil, et al.
Publicado: (2018) -
A Randomized Double‐Blind Controlled Trial of Intravenous Meloxicam in the Treatment of Pain Following Dental Impaction Surgery
por: Christensen, Steven E., et al.
Publicado: (2018) -
Evaluation of the safety and efficacy of an intravenous nanocrystal formulation of meloxicam in the management of moderate-to-severe pain after bunionectomy
por: Gottlieb, Ira J, et al.
Publicado: (2018)